Cargando…

The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis

BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Salari, Nader, Ghasemi, Hooman, Fatahian, Reza, Mansouri, Kamran, Dokaneheifard, Sadat, Shiri, Mohammad hossain, Hemmati, Mahvan, Mohammadi, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854075/
https://www.ncbi.nlm.nih.gov/pubmed/36670466
http://dx.doi.org/10.1186/s40001-023-01011-y
_version_ 1784873038268858368
author Salari, Nader
Ghasemi, Hooman
Fatahian, Reza
Mansouri, Kamran
Dokaneheifard, Sadat
Shiri, Mohammad hossain
Hemmati, Mahvan
Mohammadi, Masoud
author_facet Salari, Nader
Ghasemi, Hooman
Fatahian, Reza
Mansouri, Kamran
Dokaneheifard, Sadat
Shiri, Mohammad hossain
Hemmati, Mahvan
Mohammadi, Masoud
author_sort Salari, Nader
collection PubMed
description BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalence of different primary CNS tumors. METHOD: The study was conducted as a systematic review and meta-analysis by searching international databases, including PubMed, Scopus, Science Direct, Web of science, and the Google Scholar search engine until August 2020. After transferring the studies to information management software (EndNote) and eliminating duplicate studies, the remaining studies were reviewed based on inclusion and exclusion criteria according to three stages of primary and secondary evaluation and qualitative evaluation. Comprehensive Meta-Analysis software, Begg, Mazumdar, and I(2) tests were used for data analysis, publication bias analysis, and heterogeneity analysis, respectively. RESULTS: After performing the systematic review steps, 80 studies were included for final analysis. Based on 8 studies, the prevalence of brain tumors was 70.9%. Also, studies on 7 other studies showed that the prevalence of spinal tumors was 12.2%. A review of 14 studies showed that the prevalence of neuroepithelial tumors was 34.7%. The analysis of 27 studies reported a prevalence of glioma tumors of 42.8%. Analyses performed on other studies showed that the prevalence of pituitary adenomas was 12.2%, embryonal tumors 3.1%, ependymal tumors 3.2%, meningiomas 24.1%, glial tumors 0.8%, astrocytic 20.3%, oligodendroglial 3.9%, glioblastoma 17.7%, schwannoma 6.7%, medulloblastoma 7.7% and Polycystic astrocytomas 3.8%. CONCLUSION: As a result, it can be stated that brain tumors are the most common type of primary CNS tumors. It was also observed that tumors involving neuroepithelial cells are more common in patients than other types of tumors.
format Online
Article
Text
id pubmed-9854075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98540752023-01-21 The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis Salari, Nader Ghasemi, Hooman Fatahian, Reza Mansouri, Kamran Dokaneheifard, Sadat Shiri, Mohammad hossain Hemmati, Mahvan Mohammadi, Masoud Eur J Med Res Research BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalence of different primary CNS tumors. METHOD: The study was conducted as a systematic review and meta-analysis by searching international databases, including PubMed, Scopus, Science Direct, Web of science, and the Google Scholar search engine until August 2020. After transferring the studies to information management software (EndNote) and eliminating duplicate studies, the remaining studies were reviewed based on inclusion and exclusion criteria according to three stages of primary and secondary evaluation and qualitative evaluation. Comprehensive Meta-Analysis software, Begg, Mazumdar, and I(2) tests were used for data analysis, publication bias analysis, and heterogeneity analysis, respectively. RESULTS: After performing the systematic review steps, 80 studies were included for final analysis. Based on 8 studies, the prevalence of brain tumors was 70.9%. Also, studies on 7 other studies showed that the prevalence of spinal tumors was 12.2%. A review of 14 studies showed that the prevalence of neuroepithelial tumors was 34.7%. The analysis of 27 studies reported a prevalence of glioma tumors of 42.8%. Analyses performed on other studies showed that the prevalence of pituitary adenomas was 12.2%, embryonal tumors 3.1%, ependymal tumors 3.2%, meningiomas 24.1%, glial tumors 0.8%, astrocytic 20.3%, oligodendroglial 3.9%, glioblastoma 17.7%, schwannoma 6.7%, medulloblastoma 7.7% and Polycystic astrocytomas 3.8%. CONCLUSION: As a result, it can be stated that brain tumors are the most common type of primary CNS tumors. It was also observed that tumors involving neuroepithelial cells are more common in patients than other types of tumors. BioMed Central 2023-01-20 /pmc/articles/PMC9854075/ /pubmed/36670466 http://dx.doi.org/10.1186/s40001-023-01011-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Salari, Nader
Ghasemi, Hooman
Fatahian, Reza
Mansouri, Kamran
Dokaneheifard, Sadat
Shiri, Mohammad hossain
Hemmati, Mahvan
Mohammadi, Masoud
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title_full The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title_fullStr The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title_full_unstemmed The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title_short The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
title_sort global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854075/
https://www.ncbi.nlm.nih.gov/pubmed/36670466
http://dx.doi.org/10.1186/s40001-023-01011-y
work_keys_str_mv AT salarinader theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT ghasemihooman theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT fatahianreza theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT mansourikamran theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT dokaneheifardsadat theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT shirimohammadhossain theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT hemmatimahvan theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT mohammadimasoud theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT salarinader globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT ghasemihooman globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT fatahianreza globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT mansourikamran globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT dokaneheifardsadat globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT shirimohammadhossain globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT hemmatimahvan globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis
AT mohammadimasoud globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis